(NYSE: AVNS) Avanos Medical's forecast annual revenue growth rate of 0.07% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.54%.
Avanos Medical's revenue in 2023 is $749,900,000.On average, 3 Wall Street analysts forecast AVNS's revenue for 2023 to be $31,459,033,342, with the lowest AVNS revenue forecast at $31,340,508,865, and the highest AVNS revenue forecast at $31,569,386,920. On average, 3 Wall Street analysts forecast AVNS's revenue for 2024 to be $33,158,209,168, with the lowest AVNS revenue forecast at $33,115,358,368, and the highest AVNS revenue forecast at $33,194,281,835.
In 2025, AVNS is forecast to generate $34,893,736,214 in revenue, with the lowest revenue forecast at $34,823,819,307 and the highest revenue forecast at $34,990,951,355.